CLGN - CollPlant Biotechnologies Ltd

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 2.32

Open

$ 2.30

Bid

$ 2.25 x 88

Ask

$ 2.62 x 1

Day's Range

$ 2.28 - $ 2.36

52 Week Range

$ 1.31 - $ 4.98

Volume

18,212

Average Volume

Market Cap

26.57M

Beta (5Y Monthly)

$ 0.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Mayo Clinic Develops First Fully Humanized...
10/16/2025 11:07:13

The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research.According to a scie...

CollPlant Biotechnologies Announced That R...
10/16/2025 11:06:58

12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

CollPlant Biotechnologies Announces Result...
09/30/2025 11:04:19

CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcomi...

D. Boral Capital Maintains Buy on CollPlan...
09/16/2025 11:07:44

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price ...

12 Health Care Stocks Moving In Thursday's...
08/21/2025 21:06:06

Analyst Expectations For CollPlant Biotech...
08/21/2025 13:01:57

HC Wainwright & Co. Reiterates Buy on Coll...
08/21/2025 11:27:02

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

D. Boral Capital Maintains Buy on CollPlan...
08/20/2025 13:14:02

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price ...

CollPlant Biotechnologies Q2 Adj. EPS $(0....
08/20/2025 11:01:30

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estim...

Earnings Scheduled For August 20, 2025
08/20/2025 08:32:11

What's Next: CollPlant Biotechnologies's E...
08/19/2025 15:04:00

CollPlant Taps Bowman Bagley to Lead North...
07/14/2025 11:04:54

CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and ...

12 Health Care Stocks Moving In Monday's A...
06/09/2025 21:06:01

CollPlant Biotechnologies Expands Agreemen...
06/09/2025 11:05:43

CollPlant's proprietary rhCollagen to be used in clinical and commercial applicationsREHOVOT, Israel, June 9, 2025 /PRNewsw...

CollPlant Secures European Patent For rhCo...
06/04/2025 11:11:41

- Further protection granted in key territory applying to the significant and growing aesthetic and reconstructive markets -

dow-edges-higher-dell-shares-fall-after-q1-results

Dow Edges Higher; Dell Shares Fall After Q...
05/30/2025 18:55:53

12 Health Care Stocks Moving In Friday's I...
05/30/2025 17:06:00

nasdaq-down-100-points-chicago-pmi-dips-in-may

Nasdaq Down 100 Points; Chicago PMI Dips I...
05/30/2025 15:47:37

D. Boral Capital Maintains Buy on CollPlan...
05/30/2025 15:37:51

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price ...